LAWLOR, Rita Teresa
 Distribuzione geografica
Continente #
NA - Nord America 11.699
EU - Europa 10.398
AS - Asia 8.145
SA - Sud America 1.364
Continente sconosciuto - Info sul continente non disponibili 531
AF - Africa 346
OC - Oceania 63
Totale 32.546
Nazione #
US - Stati Uniti d'America 11.266
RU - Federazione Russa 4.069
SG - Singapore 3.022
CN - Cina 2.107
IT - Italia 1.931
GB - Regno Unito 1.497
BR - Brasile 1.071
HK - Hong Kong 808
VN - Vietnam 743
DE - Germania 603
IE - Irlanda 476
SE - Svezia 421
FR - Francia 417
BD - Bangladesh 403
KR - Corea 248
FI - Finlandia 243
CA - Canada 216
NL - Olanda 176
IN - India 170
JP - Giappone 98
MX - Messico 97
ES - Italia 94
UA - Ucraina 92
AR - Argentina 86
AT - Austria 81
ID - Indonesia 75
TR - Turchia 75
PL - Polonia 61
ZA - Sudafrica 60
NG - Nigeria 58
AU - Australia 54
EC - Ecuador 54
IQ - Iraq 52
JO - Giordania 52
TG - Togo 50
PK - Pakistan 45
BE - Belgio 42
VE - Venezuela 41
CO - Colombia 39
BJ - Benin 32
SA - Arabia Saudita 32
MA - Marocco 30
UZ - Uzbekistan 30
KE - Kenya 28
CL - Cile 26
IR - Iran 23
LT - Lituania 22
CH - Svizzera 21
PY - Paraguay 20
CR - Costa Rica 19
CZ - Repubblica Ceca 19
JM - Giamaica 19
MY - Malesia 17
PH - Filippine 17
BF - Burkina Faso 15
EG - Egitto 15
TN - Tunisia 15
ET - Etiopia 13
TH - Thailandia 12
AE - Emirati Arabi Uniti 11
AZ - Azerbaigian 11
HR - Croazia 11
IL - Israele 11
KG - Kirghizistan 11
NP - Nepal 11
PT - Portogallo 11
RO - Romania 11
TT - Trinidad e Tobago 11
BG - Bulgaria 10
HN - Honduras 10
LV - Lettonia 10
NI - Nicaragua 10
RS - Serbia 10
SV - El Salvador 10
GR - Grecia 9
OM - Oman 9
UY - Uruguay 9
BO - Bolivia 8
DZ - Algeria 8
GT - Guatemala 8
PA - Panama 8
SK - Slovacchia (Repubblica Slovacca) 8
AM - Armenia 7
DO - Repubblica Dominicana 7
PE - Perù 7
SI - Slovenia 7
TW - Taiwan 7
AL - Albania 6
BB - Barbados 6
HU - Ungheria 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
LB - Libano 5
MD - Moldavia 5
PS - Palestinian Territory 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
CY - Cipro 4
EE - Estonia 4
LU - Lussemburgo 4
Totale 31.945
Città #
Singapore 1.612
Ashburn 1.490
Moscow 1.403
San Jose 1.303
Southend 1.154
Dallas 1.086
Chandler 946
Verona 828
Hong Kong 790
Council Bluffs 519
Beijing 456
Dublin 434
The Dalles 423
New York 351
Jacksonville 252
Los Angeles 229
Ann Arbor 213
Ho Chi Minh City 198
Woodbridge 184
Munich 175
Santa Clara 170
Hanoi 145
Lawrence 134
Princeton 134
Wilmington 130
Jinan 123
Houston 121
Buffalo 115
São Paulo 107
Redondo Beach 99
Nanjing 93
Milan 90
Helsinki 89
Shenyang 88
Redmond 87
Columbus 85
Dong Ket 82
London 79
Tokyo 74
Nuremberg 66
Sindelfingen 66
Hebei 65
Orem 61
Seattle 60
Montreal 59
Zhengzhou 59
Rome 58
Abuja 52
Tianjin 52
Phoenix 51
Lomé 50
Turku 50
Amman 49
Chicago 47
Vienna 47
Warsaw 47
Amsterdam 46
Frankfurt am Main 46
Denver 45
Washington 45
Guangzhou 44
Toronto 44
Brooklyn 43
Brussels 42
Madrid 42
Jakarta 41
Lappeenranta 41
Haikou 40
Stockholm 40
Changsha 39
Hangzhou 39
Johannesburg 39
Mexico City 38
Ningbo 38
Nanchang 36
Poplar 36
Haiphong 35
Atlanta 34
Taizhou 34
Rio de Janeiro 33
Chennai 32
Cotonou 32
Jiaxing 32
Seoul 32
Brescia 31
Manchester 31
Falkenstein 30
Redwood City 30
Taiyuan 30
Da Nang 29
McKinney 29
Bologna 28
Naples 28
San Francisco 28
Dearborn 27
Shanghai 27
Curitiba 26
Tashkent 26
Ankara 25
Belo Horizonte 25
Totale 18.568
Nome #
Common Minimum Technical Standards and Protocols for Biobanks Dedicated to Cancer Research 608
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 311
Whole-genome landscape of pancreatic neuroendocrine tumours 294
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 291
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 275
Genomic characterization of hepatoid tumors: context matters 272
Genomic analyses identify molecular subtypes of pancreatic cancer 269
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 260
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 259
1177PUndiscovered immune heterogeneity in pancreatic adenocarcinoma (PDAC) 258
Gα15 in early onset of pancreatic ductal adenocarcinoma 250
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 247
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. 246
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 234
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 230
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 230
A multimodality test to guide the management of patients with a pancreatic cyst 229
RON is not a prognostic marker for resectable pancreatic cancer 226
CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas 226
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature 220
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation 216
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 215
Sex differences in oncogenic mutational processes 215
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer 215
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 214
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 213
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 211
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 207
Ampulla of Vater carcinoma: Molecular landscape and clinical implications 207
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients 206
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 205
428OImmune landscape of pancreatic neuroendocrine tumours (PanNETs) 205
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 204
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 204
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns 203
Reporting tumor molecular heterogeneity in histopathological diagnosis 203
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation 202
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 202
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 202
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer 201
A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk 201
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 201
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 199
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 199
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 198
Divergent mutational processes distinguish hypoxic and normoxic tumours 196
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 196
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer 196
Author Correction: The landscape of viral associations in human cancers 195
Lost in translation: returning germline genetic results in genome-scale cancer research 194
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms 193
Comparative Lesions Analysis Through a Targeted Sequencing Approach 193
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 193
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 192
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 192
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 190
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 189
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 187
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 184
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 182
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 182
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 181
Hypermutation In Pancreatic Cancer 180
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 179
Research capacity. Enabling the genomic revolution in Africa 179
Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk 179
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 178
Splice variants as novel targets in pancreatic ductal adenocarcinoma 178
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan 177
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 175
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 175
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 175
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study 175
Loss of FGFR4 promotes the malignant phenotype of PDAC 174
Pan-cancer analysis of whole genomes 174
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 173
Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids 173
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 171
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 170
International network of cancer genome projects 169
Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma 168
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations 167
Genome-wide association study identifies an early onset pancreatic cancer risk locus 167
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer 166
Exosomal miRNA signatures of pancreatic lesions 166
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients 166
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 166
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 164
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 164
A Model of Collaboration ad Experiences between Bio-industry and Academic Biobanks 162
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 161
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis 160
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 160
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 159
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes 159
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 159
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 158
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 157
Long-term organoid culture of a small intestinal neuroendocrine tumor 155
Whole genomes redefine the mutational landscape of pancreatic cancer 155
Totale 20.211
Categoria #
all - tutte 112.858
article - articoli 107.175
book - libri 1.288
conference - conferenze 1.428
curatela - curatele 0
other - altro 1.253
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.714
Totale 225.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022762 0 0 0 114 52 33 54 90 51 32 81 255
2022/20232.624 160 320 203 439 219 619 45 165 291 35 89 39
2023/20241.877 57 124 125 168 177 330 95 192 56 129 305 119
2024/20255.563 298 285 329 815 309 299 429 340 704 346 522 887
2025/202615.304 1.058 735 1.147 2.330 3.522 957 1.336 873 1.319 908 534 585
2026/20271.925 213 441 599 672 0 0 0 0 0 0 0 0
Totale 32.546